[1] |
Qiu, J. Traditional medicine: a culture in the balance.Nature. 2007, 448, 126–128.
|
[2] |
Ma, Z.T.; Yang, X.W.; Zhang, Y.; Liu, J.X. Pharmacochemistry and integrated pharmacokinetics of six alkaloids after oral administration of Huang-Lian-Jie-Du-Tang Decoction. J. Asian Nat. Prod. Res. 2014, 16, 483–496.
|
[3] |
Zhang, Y.; Liu, C.X.; Li, L.; Yang, X.W.; Liu, D.C.; Lin, C.R.; Liu, J.X. Pharmacokinetics of Tongmai granule in acute myocardialischemic model beagles. Chin. J. Chin. Mater. Med. 2016, 41, 737–742.
|
[4] |
Hu, C.Q.; Li, F.; Yang, X.W. Simultaneous determination and pharmacokinetic analysis of seven alkaloids and two flavonoids from rat plasma by HPLC-DAD after oral administration of Wuzhuyu Decoction. J. Asian Nat. Prod. Res. 2012, 14, 370–381.
|
[5] |
Qian, P.; Zhang, Y.B.; Yang, Y.F.; Xu, W.; Yang, X.W. Pharmacokinetics studies of 12 alkaloids in rat plasma after oral administration of Zuojin and fan-Zuojin formulas. Molecules. 2017, 22, 214.
|
[6] |
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China, Volume I. China Medical Science and Technology Press, Beijing, 2020, 1428.
|
[7] |
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China, Volume I. China Medical Science and Technology Press, Beijing, 2020, 109–110.
|
[8] |
Wei, W.; Xu, W.; Yang, X.W.; He, Z.M. Chemical constituents from ethyl acetate soluble parts in roots of Angelica dahurica var. formosana. Chin. Tradit. Herb. Drugs. 2016, 47, 2606–2613.
|
[9] |
Wei, W.; Yang, X.W.; Zhou, Y.Y. Chemical constituents from n-butanol soluble parts of roots of angelica dahurica cv. hangbaizhi. Mod. Chin. Med. 2017, 19, 630–634.
|
[10] |
Wei, W.; Wu, X.W.; Deng, G.G.; Yang, X.W. Anti-inflammatory coumarins with short- and long-chain hydrophobic groups from roots of Angelica dahurica cv. Hangbaizhi. Phytochemistry. 2016, 123, 58–68.
|
[11] |
Deng, G.G; Yang, X.W.; Zhang, Y.B.; Xu, W.; Wei, W.; Chen, T.L. Chemical constituents from lipophilic parts in roots of Angelica dahurica var. formosana cv. Chuanbaizhi. Chin. J. Chin. Mater. Med. 2015, 40, 2148–2156.
|
[12] |
Deng, G.G.; Wei, W.; Yang, X.W.; Zhang, Y.B.; Xu, W.; Gong, N.B.; Lv, Y.; Wang, F.F. New coumarins from the roots of Angelica dahurica var. formosana cv. Chuanbaizhi and their inhibition on NO production in LPS-activated RAW264.7 cells. Fitoterapia. 2015, 101, 194–200.
|
[13] |
Deng, G.G.; Gui, Z.J.; Yang, X.W. Chemical constituents from polarity part in roots of Angelica dahurica var. formosana cv. Chuanbaizhi. Chin. J. Chin. Mater. Med. 2015. 40, 3805–3810.
|
[14] |
Zhao, A.H.; Yang, X.W. New natural product from lipophilic parts in roots of Angelica dahurica. Chin. Tradit. Herb. Drugs. 2014, 45, 1820–1828.
|
[15] |
Zhao, A.H.; Yang, X.W.; Yang, X.B.; Liu, J.X.; Wang, Q.L.; Wang, W.Q. A new natural product from root of Angelica dahurica cv. Qibaizhi. Chin. J. Chin. Mater. Med. 2012, 37, 2400–2407.
|
[16] |
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China, Volume I. China Medical Science and Technology Press, Beijing, 2020, 42–43.
|
[17] |
Wei, W.; Xu, W.; Yang, X.W. Chemical constituents from Chuanxiong rhizoma in standardization implantation. Chin. Tradit. Herb. Drugs. 2017, 48, 3017–3025.
|
[18] |
Wei, W.; Wu, X.W.; Yang, X.W. Novel phthalide derivatives from the rhizomes of Ligusticum chuanxiong and their inhibitory effect against lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. RSC Adv. 2016, 66, 61037–61046.
|
[19] |
Zhao, A.H.; Zhang, Y.B.; Yang, X.W. Simultaneous determination and pharmacokinetics of sixteen Angelicae dahurica coumarins in vivo by LC-ESI-MS/MS following oral delivery in rats. Phytomedicine. 2016, 23, 1029–1036.
|
[20] |
Li, W.X.; Guo, J.M.; Tang, Y.P.; Wang, H.; Huang, M.Y.; Qian, D.W.; Duan, J.N. Pharmacokinetic comparison of ferulic acid in normal and blood deficiency rats after oral administration of Angelica sinensis, Ligusticum chuanxiong and their combination. Int. J. Mol. Sci. 2012, 13, 3583–3597.
|
[21] |
He, C.Y.; Wang, S.; Feng, Y.; Liang, S.; Lin, X.; Xu, D.S.; Ruan, K.F. Pharmacokinetics, tissue distribution and metabolism of senkyunolide I, a major bioactive component in Ligusticum chuanxiong Hort. (Umbelliferae). J. Ethnopharmacol. 2012, 142, 706–713.
|
[22] |
Zhao, X.; Ma, T.C.; Zhang, C.N.; Shi, S.H.; Cui, S.J.; Bi, K.S.; Jia, Y. Simultaneous determination of senkyunolide I and senkyunolide H in rat plasma by LC-MS: application to a comparative pharmacokinetic study in normal and migrainous rats after oral administration of Chuanxiong Rhizoma extract. Biomed. Chromatogr. 2015, 29, 1297–1303.
|
[23] |
Deng, H.Z.; Chen, Y.Y.; Chen, J.H.; Xiao, W. Tests of the pharmacodynamics and toxicity of Duliang Capsule. Acad. J. First Mil. Med. Univ. 2002, 22, 561–563.
|
[24] |
Yu, S.Y.; Hu, Y.Q.; Wan, Q.; Zhou, J.Y.; Liu, X.F.; Qiao, X.Y.; Yang, X.S.; Feng, J.C.; Chen, K.N.; Pan, X.P.; Yang, Q.W.; Dou, L.S.; Liu, M.; Chen, Y.M.; Yu, T.M.; Yu, J.M.; Li, Z.W.; Bai, X.; Duan, J.F. A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of Duliang soft capsule in patients with chronic daily headache. Evid. Based Complement. Alternat. Med. 2015, 2015, 694061.
|
[25] |
Wei, W.; Wang, L.; Liang, L.; Wang, Y.Z.; Hai, L.N.; Yang, X.W. Chemical constituents from couplet medicine of "Duliang" pill. Mod. Chin. Med. 2017, 19, 944–955.
|
[26] |
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine: Guidance for Industry, Bioanalytical Method Validation. USA, 2013, http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm368107.pdf.
|
[27] |
Zhou, J.C.; Liu, C.S.; Hou, Q.X.; Li, Y.; Wang, D. Application review of the commonly used pharmacokinetic softwares in China. Pharm. J. Chin. PLA. 2017, 33, 176–179.
|
[28] |
Zhao, A.H.; Zhang, Y.B.; Yang, X.W. Simultaneous determination and pharmacokinetics of sixteen Angelicae dahurica coumarins in vivo by LC-ESI-MS/MS following oral delivery in rats. Phytomedicine. 2016, 23, 1029–1036.
|
[29] |
Shi, B.M.; Liu, J.H., Zhang, Q.; Wang, S.X.; Jia, P.; Bian, L.J.; Zheng, X.H. Effect of co-administration of Acori Tatarinowii Rhizoma volatile oil on pharmacokinetic fate of xanthotoxol, oxypeucedanin hydrate, and byakangelicin from Angelicae Dahuricae Radix in rat. J. Sep. Sci. 2020, 43, 2349–2362.
|
[30] |
Wang, Q.H.; Yan, T.; Jiang, W.; Hu, N.; Zhang, S.; Yang, P.; Zhang, W.J.; Shi, L.; Liu, L.N. Simultaneous quantification of ligustilide, dl-3-n-butylphthalide and senkyunolide A in rat plasma by GC-MS and its application to comparative pharmacokinetic studies of Rhizoma Chuanxiong extract alone and Baizhi Chuanxiong Decoction. Biomed. Chromatogr. 2019, 33, e4625.
|